Psychopharmacology

Latest News

Study Finds Zuranolone Effective for Anhedonia in Patients With PPD
Study Finds Zuranolone Effective for Anhedonia in Patients With PPD

May 20th 2025

Poster presented at the APA Annual Meeting finds zuranolone effective for anhedonia associated with PPD.

Novel PDE10A Inhibitor for Acute Schizophrenia Exacerbation Presented at APA Annual Meeting
Novel PDE10A Inhibitor for Acute Schizophrenia Exacerbation Presented at APA Annual Meeting

May 18th 2025

delirium
Antipsychotics and the QTc Interval During Delirium in the Intensive Care Unit: A Secondary Analysis of a Randomized Clinical Trial

May 9th 2025

The “DIY” Psychiatry Movement: A Potential Threat to Patient Welfare and Well-Being
The “DIY” Psychiatry Movement: A Potential Threat to Patient Welfare and Well-Being

May 5th 2025

deprescribing
Deprescribing: Does the Term Belong in the Psychiatric Lexicon?

May 5th 2025

Video Interviews
Podcasts
Latest CME Events & Activities

Expert Perspectives in the Recognition and Management of Postpartum Depression

View More

Southern California Psychiatry Conference

July 11-12, 2025

Register Now!

SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era

View More

Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists

View More

BURST CME™ Part I: Understanding the Impact of Huntington’s Disease

View More

Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease

View More

Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea

View More

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

View More

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

View More

Southern Florida Psychiatry Conference

November 21-22, 2025

Register Now!

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

View More

Optimizing Care for Patients With Tardive Dyskinesia

View More

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

View More

More News

© 2025 MJH Life Sciences

All rights reserved.